Gaonkar, R.H.; Wiesmann, F.; Del Pozzo, L.; McDougall, L.; Zanger, S.; Mikołajczak, R.; Mansi, R.; Fani, M.
SPECT Imaging of SST2-Expressing Tumors with 99mTc-Based Somatostatin Receptor Antagonists: The Role of Tetraamine, HYNIC, and Spacers. Pharmaceuticals 2021, 14, 300.
https://doi.org/10.3390/ph14040300
AMA Style
Gaonkar RH, Wiesmann F, Del Pozzo L, McDougall L, Zanger S, Mikołajczak R, Mansi R, Fani M.
SPECT Imaging of SST2-Expressing Tumors with 99mTc-Based Somatostatin Receptor Antagonists: The Role of Tetraamine, HYNIC, and Spacers. Pharmaceuticals. 2021; 14(4):300.
https://doi.org/10.3390/ph14040300
Chicago/Turabian Style
Gaonkar, Raghuvir Haridas, Fabius Wiesmann, Luigi Del Pozzo, Lisa McDougall, Sandra Zanger, Renata Mikołajczak, Rosalba Mansi, and Melpomeni Fani.
2021. "SPECT Imaging of SST2-Expressing Tumors with 99mTc-Based Somatostatin Receptor Antagonists: The Role of Tetraamine, HYNIC, and Spacers" Pharmaceuticals 14, no. 4: 300.
https://doi.org/10.3390/ph14040300
APA Style
Gaonkar, R. H., Wiesmann, F., Del Pozzo, L., McDougall, L., Zanger, S., Mikołajczak, R., Mansi, R., & Fani, M.
(2021). SPECT Imaging of SST2-Expressing Tumors with 99mTc-Based Somatostatin Receptor Antagonists: The Role of Tetraamine, HYNIC, and Spacers. Pharmaceuticals, 14(4), 300.
https://doi.org/10.3390/ph14040300